World's Best Scientists 2026 revealed!
Award Badge
Microbiology
Switzerland
2025

D-Index & Metrics

Microbiology

D-Index
92
Citations
35507
World Ranking
616
National Ranking
14

Medicine

D-Index
92
Citations
35851
World Ranking
11192
National Ranking
149

Research.com Recognitions

  • 2025 - Research.com Microbiology in Switzerland Leader Award

Overview

Enos Bernasconi is affiliated with the Universita della Svizzera Italiana in Switzerland. Their research primarily spans the field of medicine, with a notable focus on infectious diseases, epidemiology, virology, emergency medicine, and hepatology.

The scientist has contributed significantly to topics including HIV/AIDS research and interventions, HIV research and treatment, HIV/AIDS drug development and treatment, HIV-related health complications and treatments, COVID-19 clinical research studies, HIV, drug use, and sexual risk, as well as hepatitis C virus research.

Enos Bernasconi's notable recent papers include:

  • Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology, 2020, Cell
  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19, 2020, JAMA
  • Cohort Profile Update: The Swiss HIV Cohort Study (SHCS), 2021, International Journal of Epidemiology
  • Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV, 2021, Annals of Internal Medicine
  • Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis, 2021, JAMA Neurology

Frequent co-authors collaborating with Enos Bernasconi include:

  • Huldrych F. Günthard
  • Alexandra Calmy
  • Matthias Cavassini
  • Roger D. Kouyos
  • Dominique L. Braun

Publications are frequently found in the following venues:

  • Clinical Infectious Diseases
  • The Journal of Infectious Diseases
  • Open Forum Infectious Diseases
  • HIV Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

    Andri Rauch;Zoltán Kutalik;Zoltán Kutalik;Patrick Descombes;Tao Cai

  • Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology.

    Luca Piccoli;Young Jun Park;M. Alejandra Tortorici;M. Alejandra Tortorici;Nadine Czudnochowski

  • Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.

    Christoph D. Spinner;Robert L. Gottlieb;Gerard J. Criner;José Ramón Arribas López

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study

    Alison J Rodger;Valentina Cambiano;Tina Bruun;Pietro Vernazza

  • Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study

    Barbara Hasse;Bruno Ledergerber;Hansjakob Furrer;Manuel Battegay

  • AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

    Bruno Ledergerber;M. Egger;V. Erard;R. Weber

  • A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.

    Markus Cornberg;Homie A. Razavi;Alfredo Alberti;Enos Bernasconi

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years: The Swiss HIV Cohort Study

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

  • Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

    Jacques Fellay;Bruno Ledergerber;Enos Bernasconi;Hansjakob Furrer

  • Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study

    R Weber;M Ruppik;M Rickenbach;A Spoerri

  • Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy.

    Gilbert R. Kaufmann;Hansjakob Furrer;Bruno Ledergerber;Luc Perrin

  • Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort Study.

    Hansjakob Furrer;Matthias Egger;Milos Opravil;Enos Bernasconi

  • Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study

    Bruno Ledergerber;Hansjakob Furrer;Martin Rickenbach;Roger Lehmann

  • Hepatitis C Virus Infections in the Swiss HIV Cohort Study: A Rapidly Evolving Epidemic

    Gilles Wandeler;Thomas Gsponer;Andrea Bregenzer;Huldrych F. Günthard

  • Hyperlactatemia and Antiretroviral Therapy: The Swiss HIV Cohort Study

    K. Boubaker;Markus Flepp;Philippe Sudre;Hansjakob Furrer

  • CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1 : results of the staccato randomised trial

    Jintanat Ananworanich;Angèle Gayet-Ageron;Michelle Le Braz;Wisit Prasithsirikul

  • Unsafe Sex and Increased Incidence of Hepatitis C Virus Infection among HIV-Infected Men Who Have Sex with Men: The Swiss HIV Cohort Study

    Andri Rauch;Martin Rickenbach;Rainer Weber;Bernard Hirschel

  • Life expectancy in HIV-positive persons in Switzerland: matched comparison with general population.

    Aysel Gueler;André Moser;Alexandra Calmy;Huldrych F. Günthard

  • Incidence of tuberculosis among HIV-Infected patients receiving highly active antiretroviral therapy in Europe and North America

    E. Girardi;C.A. Sabin;A. d'Arminio Monforte;B. Hogg

  • CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years

    Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil

Frequent Co-Authors

Matthias Cavassini
Matthias Cavassini University of Lausanne
Hansjakob Furrer
Hansjakob Furrer University of Bern
Manuel Battegay
Manuel Battegay University Hospital of Basel
Pietro Vernazza
Pietro Vernazza University of St. Gallen
Huldrych F. Günthard
Huldrych F. Günthard University of Zurich
Alexandra Calmy
Alexandra Calmy University of Geneva
Andri Rauch
Andri Rauch University of Bern
Rainer Weber
Rainer Weber University of Zurich
Bruno Ledergerber
Bruno Ledergerber University of Zurich
Sabine Yerly
Sabine Yerly University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens doors to diverse career options, including healthcare, research, and biotechnology. For those seeking education opportunities with flexibility, exploring the best associate degrees for felons can provide valuable insights into accessible programs that accommodate a wide range of backgrounds.

Healthcare careers related to microbiology are expanding rapidly. For individuals interested in patient-centered roles, programs like functional medicine NP programs offer specialized training to become nurse practitioners who integrate microbiological knowledge into holistic care approaches.

On the administrative side, becoming a Certified Professional Coder (CPC) is a viable pathway. Understanding medical codes is crucial in managing healthcare data effectively, and the cpc credential can lead to rewarding career opportunities.

Additionally, microbiology graduates interested in health information can explore roles like Health Information Manager, where they oversee health data and compliance. Learning about the health information manager salary and career paths helps gauge the potential growth in this field.

Best Scientists Citing Enos Bernasconi

Trending Scientists